Diloxanide
Diloxanide is a medication used to treat amoeba infections. In places where infections are not common, it is a second line treatment after paromomycin when a person has no symptoms. For people who are symptomatic, it is used after treatment with metronidazole or tinidazole. It is taken by mouth.
Clinical data | |
---|---|
Trade names | Furamide |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Routes of administration | by mouth |
ATC code | |
Pharmacokinetic data | |
Bioavailability | 90% (diloxanide) |
Metabolism | Hydrolyzed to furoic acid and diloxanide, which undergoes extensive glucuronidation |
Elimination half-life | 3 hours |
Excretion | Kidney (90%), fecal (10%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.008.583 |
Chemical and physical data | |
Formula | C14H11Cl2NO4 |
Molar mass | 328.15 g·mol−1 |
3D model (JSmol) | |
Melting point | 112.5 to 114 °C (234.5 to 237.2 °F) |
SMILES
| |
| |
(what is this?) (verify) |
Diloxanide generally has mild side effects. Side effects may include flatulence, vomiting, and itchiness. During pregnancy it is recommended that it be taken after the first trimester. It is a luminal amebicide meaning that it only works on infections within the intestines.
Diloxanide came into medical use in 1956. It is on the World Health Organization's List of Essential Medicines. It is not commercially available in much of the developed world as of 2012.